Table 1.
Patient Characteristics.a
| Characteristic | Statistic |
|---|---|
| No. patients | 18 |
| Age, years | 57 [43-75] |
| Female | 10 (56) |
| KPS | 80 [50-90] |
| NFS | 1 [0-3] |
| Prior smoker | 8 (44) |
| Comorbid disease | |
| Body mass index | 27 ± 5 |
| Hypertension | 9 (50) |
| Hyperlipidemia | 4 (22) |
| Diabetes | 2 (11) |
| Extent of spinal disease | |
| Single level | 4 (22) |
| Multilevel (2-5 VB) | 11 (61) |
| Diffuse | 3 (17) |
| Visceral metastasesb | 10 (56) |
| Brain metastases | 1 (16) |
| Extraspinal bony metastases | 9 (50) |
| Concurrent medical therapies | |
| Concurrent steroids | 4 (22) |
| Chemotherapy | 2 (11) |
| Bisphosphonates | 2 (11) |
| No. prior chemotherapy regimens | 0 [0-5] |
| Histology | |
| Leiomyosarcoma | 6 (32) |
| Chondrosarcoma | 3 (17) |
| Spindle cell | 3 (17) |
| Pleomorphic | 2 (11) |
| Liposarcoma | 2 (11) |
| Osteosarcoma | 1 (6) |
| Myxofibrosarcoma | 1 (6) |
Abbreviations: KPS, Karnofsky Performance Status; NFS, neurologic function scale; No., number; VB, vertebral bodies.
aValues are presented as mean ± standard deviation, number (percentage), or median [range].
bOrgan metastases other than bone or brain.